Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSA | P10619 | 12/20 | 0.46 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.42 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.41 |
| ▸ | GRM5 | P41594 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | SLC6A9 | P48067 | 1/20 | 0.38 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.37 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7901954 | 0.80 | CTSA (0.48) | CTSAPDPK1SLC6A3GRM5LMNA | |
| SCHEMBL8432353 | 0.77 | CTSA (0.46) | CTSAPDPK1SLC6A3GRM5LMNA | |
| SCHEMBL6848050 | 0.77 | ALOX5 (0.52) | CTSAPDPK1SLC6A3GRM5LMNA | |
| SCHEMBL11172666 | 0.77 | KMT2A (0.47) | CTSAPDPK1SLC6A3LMNATSHR | |
| SCHEMBL17294112 | 0.74 | HTR2A (0.52) | CTSAPDPK1SLC6A3 | |
| SCHEMBL8145856 | 0.74 | HTR2A (0.52) | CTSAPDPK1SLC6A3 | |
| SCHEMBL21836232 | 0.74 | MAPKAPK2 (0.44) | CTSAPDPK1SLC6A3GRM5LMNA | |
| SCHEMBL21836233 | 0.74 | MAPKAPK2 (0.44) | CTSAPDPK1SLC6A3GRM5LMNA | |
| SCHEMBL9019045 | 0.73 | CTSA (0.43) | CTSAPDPK1SLC6A3GRM5LMNA | |
| SCHEMBL1515721 | 0.73 | CTSA (0.46) | CTSAPDPK1SLC6A3LMNATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11548012-B2 | Process to treat metal or mineral ores and collector composition therefor | NOURYON CHEMICALS INTERNATIONAL B.V. (NL) | 2023-01-10 | — | — | US | claimed |
| US-20210197210-A1 | PROCESS TO TREAT METAL OR MINERAL ORES AND COLLECTOR COMPOSITION THEREFOR | NOURYON CHEMICALS INTERNATIONAL B.V. (NL) | 2021-07-01 | — | — | US | claimed |
| EP-3600678-B1 | PROCESS TO TREAT METAL OR MINERAL ORES AND COLLECTOR COMPOSITION THEREFOR | NOURYON CHEMICALS INT BV (NL) | 2021-05-05 | — | — | EP | claimed |
| EP-3697540-A1 | PROCESS TO TREAT METAL OR MINERAL ORES AND COLLECTOR COMPOSITION THEREFOR | Nouryon Chemicals International B.V. (NL) | 2020-08-26 | — | — | EP | claimed |
| EP-3636346-A1 | PROCESS TO TREAT ORES AND COLLECTOR COMPOSITION THEREFOR | Nouryon Chemicals International B.V. (NL) | 2020-04-15 | — | — | EP | claimed |
| US-20200048735-A1 | PROCESS TO TREAT METAL OR MINERAL ORES AND COLLECTOR COMPOSITION THEREFOR | NOURYON CHEMICALS INTERNATIONAL B.V. (NL) | 2020-02-13 | — | — | US | claimed |
| EP-3600678-A1 | PROCESS TO TREAT METAL OR MINERAL ORES AND COLLECTOR COMPOSITION THEREFOR | Nouryon Chemicals International B.V. (NL) | 2020-02-05 | — | — | EP | claimed |
| US-20080308466-A1 | Mineral Recovery from Ore | LUMSDEN BARRY GRAHAM | 2008-12-18 | — | — | US | claimed |
| EP-1951433-A1 | IMPROVING MINERAL RECOVERY FROM ORE | Lumsden, Barry Graham (AU) | 2008-08-06 | — | — | EP | claimed |
| WO-2007059559-A1 | IMPROVING MINERAL RECOVERY FROM ORE | LUMSDEN BARRY GRAHAM (AU) | 2007-05-31 | — | — | WO | claimed |
| US-4414312-A | Photopolymerizable polyamide ester resin compositions containing an oxygen scavenger | E. I. DU PONT DE NEMOURS & CO. (US) | 1983-11-08 | — | — | US | claimed |
| US-11548012-B2 | Process to treat metal or mineral ores and collector composition therefor | NOURYON CHEMICALS INTERNATIONAL B.V. (NL) | 2023-01-10 | — | — | US | disclosed |
| EP-3697540-B1 | PROCESS TO TREAT METAL OR MINERAL ORES AND COLLECTOR COMPOSITION WITH A DIMERIC NITRILE | NOURYON CHEMICALS INT BV (NL) | 2022-09-28 | — | — | EP | disclosed |
| US-20210197210-A1 | PROCESS TO TREAT METAL OR MINERAL ORES AND COLLECTOR COMPOSITION THEREFOR | NOURYON CHEMICALS INTERNATIONAL B.V. (NL) | 2021-07-01 | — | — | US | disclosed |
| EP-3600678-B1 | PROCESS TO TREAT METAL OR MINERAL ORES AND COLLECTOR COMPOSITION THEREFOR | NOURYON CHEMICALS INT BV (NL) | 2021-05-05 | — | — | EP | disclosed |
| EP-2569091-A1 | SEPARATION OF MATERIALS FROM RECYCLED ELECTROCHEMICAL CELLS AND BATTERIES BY FROTH FLOTATION | RSR Technologies, Inc. (US) | 2013-03-20 | — | — | EP | disclosed |
| WO-2011143061-A1 | SEPARATION OF MATERIALS FROM RECYCLED ELECTROCHEMICAL CELLS AND BATTERIES BY FROTH FLOTATION | RSR TECHNOLOGIES, INC. (US) | 2011-11-17 | — | — | WO | disclosed |
| US-20080308466-A1 | Mineral Recovery from Ore | LUMSDEN BARRY GRAHAM | 2008-12-18 | — | — | US | disclosed |
| EP-1951433-A1 | IMPROVING MINERAL RECOVERY FROM ORE | Lumsden, Barry Graham (AU) | 2008-08-06 | — | — | EP | disclosed |
| WO-2007059559-A1 | IMPROVING MINERAL RECOVERY FROM ORE | LUMSDEN BARRY GRAHAM (AU) | 2007-05-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11548012-B2 | Process to treat metal or mineral ores and collector composition therefor | AFF4, FFAR4, FUS | CTSA 4214/4885PDPK1 4202/4885SLC6A3 3134/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.